Trial
NCT05420636
Iadademstat in Combination With Paclitaxel in Relapsed/Refractory SCLC and Extrapulmonary High Grade NET
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Fox Chase Cancer Center
Collaborators
Oryzon Genomics S.A.
Condition
Small-cell Lung Cancer
Intervention
Iadademstat
Why stopped
Closed to accrual due to low probability of successful outcomes
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-30